Obesity increases the body's need for insulin, forcing cells in the pancreas known as beta cells to ramp up insulin ...

India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.

GentiBio, Inc., a clinical-stage biotechnology company pioneering engineered, antigen-specific regulatory T cell (EngTreg) therapies, today announced that the first participant has been dosed in ...

The former NBA All-Star has lost near 100 pounds in recent years.

Metabolic syndrome increases risk for heart disease and diabetes. Learn how lifestyle changes can protect children's health.

One type of intermittent fasting may reduce blood sugar and diabetes risk, according to research. Here, experts explain what ...

New trial data indicates that Tegoprubart, a CD40L-selective humanized monoclonal antibody, may help protect transplanted islet cells while avoiding the toxicities of calcineurin ...

When the 25-year-old woman from Tianjin, China, sat down to eat a bowl of hotpot- one of her favourite meals – it felt like something close to a miracle. For years, she had lived under the strict ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 drugs like Ozempic.

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

Researchers found that the risk of type 2 diabetes varies among young adults. Those with high fasting glucose who qualified for GLP-1 treatment had a higher risk of type 2 diabetes, suggesting that ...